Media & news

"After seven years, the transformation to growth is completed. We enter the next phase of Kinnevik with a strong financial position, and with a growth-focused portfolio consisting of a high-performing core and several exciting earlier stage companies with the potential to create significant outcomes. During the quarter, we continued to execute on our strategic priorities, investing more capital into our core company Spring Health and our newer venture Aira. Valuations in the core companies grew on the back of strong growth and improving margins, but a full write-down of our remaining VillageMD investment and the weaker dollar weighed on our Net Asset Value.”

Kinnevik AB (publ) ("Kinnevik") today announced that the Board has resolved to redeem a total of 258,600 incentive shares issued under Kinnevik's long-term incentive plans for 2022-2024.

Kinnevik AB (publ) ("Kinnevik") will publish its financial results for the third quarter 2024 on Wednesday 16 October 2024 at around 08.00 CET. A conference call will be held on the same day at 10.00 CET to present the results.

The venue for Kinnevik’s Capital Markets Day, between 9 – 15 CET on 23 October 2024, has been changed to Eric Ericsson Hallen, Kyrkslingan 2-4 in Stockholm.